Clinical Trial Update: Effects of Antiviral Therapy on HBV Reactivation [Phase 2, Phase 3]

View source ↗

Summary

This update reports on the effects of antiviral therapy on HBV reactivation in liver cancer patients across Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Liver Cancer | Phase 2, Phase 3 | Status: COMPLETED